Spedra (avanafil)
Spedra product identity, documented formulations and sources for European Union.
Spedra is the avanafil product covered by this EU record. The currently cited EMA page identifies Phoenix Labs Unlimited Company as its marketing authorization holder.
Keep regional records separate
Stendra is another avanafil brand with a separate US label. Similar ingredients do not justify transferring a regional company’s identity, pack details or authorization to another product.
Before treatment
Read the avanafil hub for the shared ingredient context. Timing instructions depend on the label and strength. Nitrates and certain interacting medicines are incompatible with treatment; a pharmacist should check your medicine list.
Compare ingredients · Safety and interactions
Product record
- Brand type
- Original / reference brand
- Active ingredient
- avanafil
- Formulation in the cited record
- Tablets
- Label-listed strengths
- 50, 100, 200 mg
- Company in the cited record
- Phoenix Labs Unlimited Company (EU marketing authorization holder)
- Manufacturing information
- Menarini - Von Heyden GmbH, Dresden, Germany — manufacturer responsible for batch release in the EU product information.
- Jurisdiction checked
- European Union
- Record reference
- EMEA/H/C/002581
- Sources checked
These records identify a named product and market. They do not confirm stock, authenticate a particular pack, or establish authorization in another country.